Meet our advisory council

A cadre of industry experts helping advance wireless health

Comprised of influential leaders in health care, wireless and mobile health, the Qualcomm Life Advisory Council (QLAC) is providing valued feedback to Qualcomm Life’s current and future offerings

Nancy Brown American Heart Association

Ben Chu, MD Kaiser Permanente

John Driscoll CEO, CareCentrix

Kieran Gallahue CareFusion

Matthew Holt Health 2.0

James Hummer Luxemburg Capital; Whole Health Management

Don Jones CEO, Trial Fusion

Dean Kamen DEKA Research & Development Corporation

Ilene Klein, MD, FAAFP (Chair) Qualcomm Life, Inc.; Qualcomm Incorporated

Isaac Kohane, MD Harvard Medical School

Daniel Kraft, MD FutureMed

Joseph Kvedar, MD Partners HealthCare

Arnie Milstein, MD Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC

Dana George Mead, Jr. Kleiner Perkins Caufield & Byers

Diego Miralles Janssen Healthcare Innovation; West Coast Research Center; Johnson & Johnson

Lee Shapiro Allscripts

Lisa Suennen Managing Partner at Venture Valkyrie Consulting, LLC

Eric Topol, MD Scripps Translational Science Institute

Dr. Chris Wasden Executive Director, Sorenson Center for Discovery and Innovation, University of Utah

Andrew Watson Medical Director, UPMC Telemedicine

Nancy Brown
CEO, American Heart Association

Nancy Brown has been chief executive officer of the American Heart Association (AHA) since 2009. The AHA is widely known and highly respected as the world's largest voluntary health organization dedicated to preventing, treating and defeating cardiovascular diseases and stroke. During her tenure as CEO, the AHA has become a global leader in the discovery and dissemination of heart disease and stroke science. Notably, under Nancy's leadership the AHA announced its bold new 2020 health impact goal: To improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular diseases and stroke by 20%. Nancy's drive to set a brave long-term goal, at a time when many other organizations were focused on short-term needs, has provided a rallying point for the Association's millions of volunteers and donors. Nancy has also led the organization to a number of significant advances in the time that she has served as its top staff executive; these include a laser focus on prevention and the benefits of preventive health as outlined in the AHA's 2010–13 strategic plan, creating the Vision for Volunteerism initiative to generate even more significant opportunities for volunteers to impact the AHA's mission, development of the first-ever integrated global strategy for the AHA, launching new programs to expand individual giving and increase the AHA's revenue and mission impact in small communities and instilling a culture of innovation throughout the AHA, spearheaded by the AHA's Innovation Think Tank which is comprised of staff executives and volunteer thought leaders, who have among other things, created the roadmap for future new missions and revenue business enterprises. In addition to her tireless efforts for the AHA, Nancy shares her passion for improving the health of individuals in the U.S. and globally by serving on the boards of the Campaign for Tobacco Free Kids, the National Health Council, Research! America and the Partnership for Prevention. She was also recently appointed co-chairman of the Coalition to Transform Advanced Care, which is being convened to reframe how to provide end of life care that respects patients’ wishes and ensures quality decision-making and outcomes for families and health care providers. Prior to being named CEO, Nancy served as AHA's chief operating officer for the eight prior years. In this role she managed the AHA's mission, science and business functions and led the AHA's integrated strategy to achieve its 2010 Impact Goal to reduce coronary heart disease, stroke and risk by 25%. She has held multiple leadership positions at the AHA since her start in 1986 leading fundraising initiatives in the Michigan affiliate, including serving as the executive director in Metro Detroit, as well as leading the AHA's work as executive vice president of the former Massachusetts and New England affiliates. Prior to joining the AHA, Nancy served her home state of Michigan as director of development/deputy director of the Endowment Campaign for the Michigan Cancer Foundation, and as special events director for Mount Carmel Mercy Hospital in Detroit.

back to top

Ben Chu, MD

Group President, Southern California and Hawaii, Kaiser Permanente

Benjamin Chu, MD, MPH, MACP, was appointed regional president of Kaiser Permanente Southern California in February 2005 and in January 2011 was appointed group president responsible for both Southern California and Hawaii. He directs hospital and health plan operations for 14 hospitals and 145 medical offices, serving more than 3.45 million members. As group president, he joins the Kaiser Permanente Program-wide Operational Leadership group with oversight responsibility over the entire organization. Before he joined Kaiser Permanente, Dr. Chu served for three years as president of New York City’s Health and Hospitals Corp., the largest public hospital system in the country. A primary care internist by training, Dr. Chu possesses extensive health care experience as a clinician, administrator and policy advocate. He was senior vice president for Medical and Professional Affairs for the public hospitals and served as acting commissioner of health for the New York City Department of Health from 1990 to 1994. Dr. Chu has experience as an academic health center leader. He was senior associate dean at Columbia University College of Physicians and Surgeons from July 2000 to February 2002. He also served at the New York University School of Medicine and Medical Center as associate dean and Vice President for Clinical Affairs from April 1994 to May 2000. As a 1989–1990 Robert Wood Johnson Policy Fellow, he served as a legislative assistant for health for New Jersey Senator Bill Bradley. Dr. Chu currently serves on the board of the Commonwealth Fund in New York and is chairman of the board of the American Legacy Foundation based in Washington, DC. In 2008, he completed a three-year term as an at-large board member of the American Hospital Association, serving on the executive committee during the final year. He is currently an AHA appointee to the Joint Commission Board. Dr. Chu earned his medical degree at New York University, his master’s of public health from Columbia University and a bachelor’s degree in psychology from Yale University.

back to top

John Driscoll

CEO, CareCentrix

John Driscoll brings more than 25 years of health care experience to CareCentrix as CEO. Prior to CareCentrix, John served as president at Castlight Health, a healthcare technology company. Previously John served as group president for new markets at Medco and led product development for Medco’s employer and health plan clients. Mr. Driscoll was responsible for corporate development and led Medco’s entry into Medicare, international markets and pharma services.

Mr. Driscoll founded and chaired the Surescripts ePrescribing Network. He also served as an advisor to Oak Investment Partners, and held a number of senior operating positions at Oxford Health Plans, including corporate vice president for government programs.

John has a B.A. and M.B.A. from Harvard University as well as an M.Phil from Cambridge University in England. John is the chairman of the Truman National Security Project and is an advisory board member of Bread for the World.

back to top

Kieran Gallahue

Chairman and CEO, CareFusion

Kieran Gallahue is chairman and chief executive officer of CareFusion, a global health care company with products and services that help hospitals measurably improve the safety, quality and cost of patient care. Previously, Kieran served as president, CEO and a director of ResMed, a global leader in medical equipment for treating, diagnosing and managing sleep-related respiratory disorders. He has approximately 20 years of strategic, operational and corporate management experience in the health care industry, with deep expertise in the medical technologies field. Since 2007, he has also served on the board of Volcano Corp., a developer of products for interventional cardiology. He also serves on the Executive Committee of the board of the Advanced Medical Technology Association (AdvaMed) and has been a member of the Young Presidents Organization since 2002. Prior to joining ResMed, Kieran held various general management and functional roles at Nanogen, Instrumentation Laboratory, P&G and GE. Kieran holds a Bachelor of Science degree in economics from Rutgers University and an MBA from Harvard Business School.

back to top

Matthew Holt

Blogger/Founder, Health 2.0

Matthew Holt has been in health care for over 20 years as a researcher, generalist forecaster and strategist. He is known for his work with some of the best forecasting and survey research organizations in the US including the Institute for the Future and Harris Interactive. He has conducted in-depth studies about many aspects of health care for public release and private clients. He is a well-regarded and amusing presenter and has delivered several keynote addresses. These days, Matt is best known for two things: being the founder (and now occasional) author of The Health Care Blog, which is one of the best-read blogs in health care. His day job is the co-chairman (with Indu Subaiya) of Health 2.0, the leading venue for innovative technology in health care. Health 2.0 has a large annual conference in the U.S. with other franchise conferences across the U.S. and abroad. It also offers a market intelligence and advisory service, its own media and TV channel, a platform for prize challenges and a large community of followers with chapters in more than 30 cities worldwide.

back to top

James Hummer

Founder, Luxemburg Capital; Former CEO, Whole Health Management

James Hummer ran Whole Health Management for 12 years. He was one of the first to see the opportunity in helping self-insured employers bring their health care services "into the tent." Whole Health originated as an on-site health provider to the federal sector. James purchased the business in 1987, renamed it in 1991, and by the time he sold it to Walgreens in March 2008, he was running 70 clinics for private-sector employers, including Continental Airlines, Sprint and Qualcomm. Whole Health is now part of Walgreens' Take Care Employer Solutions unit. Previously, James founded IVY Medical Group, a large ambulatory care practice and was also involved with Simplicity Health Plans. Named regional Ernst & Young Entrepreneur of The Year in 2008, James now invests in health care startups through Luxemburg Capital.

back to top

Don Jones

CEO, Trial Fusion

Donald Jones is a globally recognized leader in Digital Medicine (sometimes referred to as Wireless Health, Digital Health, Connected Health, or mHealth). He is sought out as a speaker, advisor and board member. He works with healthcare, pharmaceutical and medical device, OEM, Telcos and early stage companies. Donald Jones is the CEO of Trial Fusion, a company focused on commercializing digital health products by providing design and partnership expert advise and clinical, user experience and economic evidence required for their adoption. Jones also serves as the Chief Digital Officer of the Scripps Translational Science Institute, working with the renowned Eric Topol, MD, on the convergence of genomics and wireless health – digital medicine. He co-founded Scripps Digital Medicine, the world’s first clinical trial center focused on digital health and large data sets. For 11 years through 2014, he led Wireless Health Global Strategy and Business Development for Qualcomm. He is Founder and Chairman of the Wireless Life Sciences Alliance. Working with the XPRIZE Foundation and Qualcomm’s CEO, Jones conceived the $10 million Qualcomm Tricorder XPRIZE, a global competition for a consumer device which makes medical diagnoses. CommNexus recognized Donald Jones as 2014 Digital Health Innovator of the Year.

back to top

Dean Kamen

Inventor and Founder, DEKA Research and Development Corporation

Dean Kamen is an inventor, entrepreneur and tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the U.S. As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as chemotherapy, neonatology and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. At age 30, he sold that company to Baxter Healthcare Corporation. By then, he had added a number of other infusion devices, including the first wearable insulin pump for diabetics. Following the sale of AutoSyringe, Inc., he founded DEKA Research and Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoice™ peritoneal dialysis system for Baxter International Inc. The HomeChoice system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Dean also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVAR™ XTS™ System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the Hydroflex™ surgical irrigation pump for C.R. Bard, the Crown™ stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOT™ mobility device, and the Segway® Human Transporter. Dean has received many awards for his efforts. Notably, he was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award recognizes inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Dean was also awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST will serve more than 250,000 young people, ages 6 to 18, in more than 50 countries around the globe. High school-aged participants are eligible to apply for more than $14 million in scholarships from leading colleges, universities and corporations. Studies have shown that FIRST alumni are highly motivated to pursue careers in science and engineering, thus fulfilling Dean's goal of inspiring the next generation of technological leaders.

back to top

Ilene Klein, MD, FAAFP (Chair)

Chief Medical Advisor, Qualcomm Life, Inc.; Director of Global Employee Health Services, Qualcomm, Inc.

Ilene serves as the chief medical advisor for Qualcomm Life and director of global employee health services for Qualcomm, Inc. Ilene has more than 30 years of administrative and clinical experience in the public and private health care sectors. As the former deputy director of operations for the New York City Department of Health’s Bureau of Child Health, Ilene helped to create a city-wide network of pediatric primary care homes in underserved communities. After pursuing a career in clinical medicine, she was a partner in a private family practice in Massachusetts. There she served as the first chief of service for the new Department of Primary Care at Martha’s Vineyard Hospital. Ilene came to San Diego in 2007 to open Qualcomm’s first onsite employee health center, where she served as its medical director until June 2011. Ilene is a board- certified family physician and a Fellow of the American Academy of Family Physicians. She earned her medical degree from Harvard Medical School, where she was an Edward Kass Fellow at the East Boston Neighborhood Health Centre. She completed her residency training through the Department of Family Medicine at Brown University. Ilene holds bachelors and master’s degrees in music therapy from New York University.

back to top

Isaac Kohane, MD

Director of the Children's Hospital Informatics Program; Henderson Professor of Pediatrics and Health Sciences and Technology, Harvard Medical School

Isaac (Zak) Kohane, MD, is the director of the Children's Hospital Informatics Program and is the Henderson Professor of Pediatrics and Health Sciences and Technology at Harvard Medical School (HMS). He is also co-director of the HMS Center for Biomedical Informatics and Director of the HMS Countway Library of Medicine. Dr. Kohane leads multiple collaborations at Harvard Medical School and its hospital affiliates in the use of genomics and computer science to study cancer and the development of the brain, with an emphasis on autism. He has developed several computer systems to allow multiple hospital systems to be used as "living laboratories" to study the genetic basis of disease, while preserving patient privacy. Dr. Kohane's research builds on his doctoral work in computer science on decision-support and subsequent research in machine-learning applied to biomedicine. Dr. Kohane has led the development of cryptographic health identification systems, automated personal health records and peer-to-peer pathology information networks. Dr. Kohane leads several NIH-funded efforts to translate genomic research into clinical practice and continues his own practice in pediatric endocrinology at Children's Hospital Boston.

back to top

Daniel Kraft, MD

Founder, FutureMed

Daniel Kraft, MD, is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur and innovator. Dr. Kraft has over 20 years of experience in clinical practice, biomedical research and healthcare innovation. Daniel chairs the Medicine track for Singularity University and is executive director for FutureMed, a program that explores convergent, exponentially developing technologies and their potential in biomedicine and healthcare. Following his undergraduate degree at Brown and medical school at Stanford, Dr. Kraft was board certified in the Harvard combined internal medicine and pediatrics residency program at Massachusetts General Hospital and Children’s Hospital Boston. He went on to complete Stanford fellowships in hematology/ oncology and bone marrow transplantation, and extensive research in stem cell biology and regenerative medicine. He has multiple scientific publications (including in Nature and Science) and medical device, immunology and stem cell-related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at UCSF. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data-driven and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvesting of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. Daniel is an avid pilot and serves in the California Air National Guard as an officer and flight surgeon with an F-16 fighter squadron. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.

back to top

Joseph Kvedar, MD

Director, Center for Connected Health, Partners HealthCare

Joseph Kvedar, MD, is the founder and director of the Center for Connected Health at Partners Healthcare, which works to create a new model of health care delivery by developing programs and innovative strategies to move care from the hospital or doctor’s office into the day-to-day lives of patients. In his role with the Center for Connected Health, Dr. Kvedar is creating innovative programs to leverage information technology—cell phones, computers, networked devices and simple remote health monitoring tools—to help providers and patients manage chronic conditions, maintain health and wellness and improve adherence, engagement and clinical outcomes. Based on the technology platform developed at the Center, Healthrageous, a personalized health technology company, was launched in 2010, offering a range of health and wellness self-management programs to its clients. In addition, Dr. Kvedar also launched the first physician-to-physician online consultation service in an academic setting, which today electronically links patients from around the world and their local providers with leading specialists at Harvard-affiliated teaching hospitals. Dr. Kvedar is internationally recognized for his leadership and vision in the field of connected health and the application of communications technologies to improve health care for patients. He is a frequent lecturer and has authored over 70 publications on the subject. Dr. Kvedar serves as a board member for a number of organizations, including the Continua Health Alliance and the Care Continuum Alliance. He also is a co-founder of Healthrageous and chair of the company’s Scientific Advisory Board. Dr. Kvedar is a past president and board member of the American Telemedicine Association (ATA) and a past chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine. In 2009, Dr. Kvedar was honored by the ATA with its Individual Leadership Award, recognizing his significant contributions to connected health and telemedicine. Mass High Tech, the Journal of New England Technology named Dr. Kvedar an All-Star in the field of health care and he has been honored by the New England Business and Technology Association for his extraordinary leadership in the field. A division of Partners HealthCare, the Center for Connected Health works with Harvard Medical School-affiliated teaching hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Kvedar is also a board-certified dermatologist and associate professor of dermatology at Harvard Medical School.

back to top

Dana George Mead, Jr.

Partner, Kleiner Perkins Caufield & Byers

Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm’s life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Pulmonx, Spiracur, Spinal Modulation, and Teladoc. For the past 29 years, Dana’s career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 10 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]), OtisMed (acquired by Stryker [Nasdaq: SYK]) and Navigenics (acquired by Life Technologies [Nasdaq: LIFE]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children’s Hospital at Stanford University, and he is the chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.

back to top

Arnie Milstein, MD

Medical Director, Pacific Business Group on Health; Mercer Benefits Consulting; Stanford CERC

Arnie Milstein, MD is a professor of medicine at Stanford and directs the Stanford Clinical Excellence Research Center (CERC). The Center is a collaboration of the Schools of Medicine, Engineering and Business to design and test new health care delivery models that both lower per capita health care spending and improve clinical outcomes. His career and ongoing research is focused on the acceleration of clinical service innovations that improve the societal value of health care. He also serves as the medical director of the Pacific Business Group on Health (PBGH), the largest regional health care improvement coalition in the US. He also guides employer-sponsored, clinically based innovation development for Mercer Health and Benefits and chairs the Steering Committee that directs the largest US physician pay-for-performance program, operated by the Integrated Healthcare Association. Previously he co-founded the Leapfrog Group and Consumer-Purchaser Disclosure Project, and served as a Congressionally-appointed MedPAC Commissioner. Citing his nationally distinguished innovation in health care cost reduction and quality gains, he was selected for the highest annual award of the National Business Group on Health (NBGH) and of the American College of Medical Quality. Elected to the Institute of Medicine (IOM) of the National Academy of Sciences, he chaired the planning committee of its examination of best methods to lower per capita health care spending and improve clinical outcomes. He was educated at Harvard (BA in economics), Tufts (MD) and UC Berkeley (MPH in health services evaluation and planning).

back to top

Diego Miralles

Head, Janssen Healthcare Innovation; Head, West Coast Research Center; Head, Janssen Labs, Johnson & Johnson

Diego Miralles is the head of External Innovation for the immunology therapeutic area at Johnson & Johnson Pharmaceutical Research & Development. In this role, he is responsible for expanding the immunology R&D network through external partnerships to increase research/development capabilities and the immunology portfolio. Diego graduated from the University of Buenos Aires in 1986. From there, he completed his residency in internal medicine at the Mayo Clinic in Rochester, Minn. (1987–1990) and his fellowship in infectious diseases at Cornell University-New York Hospital (1990–1992). He was attending in charge at The AIDS Clinical Trial Unit, Beth Israel Medical Center, New York in 1993. Diego was also on the faculty at Duke University, Durham, NC, from 1993 to 1998. He continued his academic appointment and clinical HIV practice at Duke from 1993 through 2005. Diego joined Triangle Pharmaceuticals as associate director, and then director, team leader, DMP-450, in 1998–2000. He was then with Trimeris as director/senior director, clinical trials, Clinical Team Leader T-1249, in 2000–2005. He joined Tibotec/Johnson & Johnson in Belgium in June 2005 as VP, Global Clinical Development, where he oversaw the regulatory approval of Prezista and Intelence and was on the company board. Diego has also been head of the Johnson & Johnson Pharmaceutical Research and Development (PRD) Discovery site in San Diego, Calif., since August 2008.

back to top

Lee Shapiro

President, Allscripts

Lee oversees the company's strategy, government relations, mergers and acquisitions, international operations, business development and partnerships, health plan initiatives and business activities in the areas of analytics and information services. He also serves as executive sponsor for Allscripts key strategic relationships with companies such as Microsoft, Dell, Fujitsu, Henry Schein and Intuit. Since becoming president of Allscripts in 2001, Lee has led a team that develops the network of alliances that are and will continue to be critical to the company's success, with the goal of improving solutions, expanding offerings, enhancing market presence and broadening opportunities. Prior to joining Allscripts, Lee was the chief operating officer of Douglas Elliman-Beitler, a premier commercial office management and development company, where he directed all business activities throughout the United States. Lee also previously served as president of SES Properties, Inc., a closely held, fully integrated real estate company and, at that time, the largest retail developer in Las Vegas. Concurrently, Lee formed City Financial Bancorp and served as its vice chairman. He was responsible for the acquisition of financial institutions, financing, regulatory issues, legal affairs and the restructuring of operations, leading to the ultimate sale of this $100 million holding company. Lee serves on the boards of Medidata Solutions [Nasdaq:MDSO], Perseus Acquisition LLC (Physicians Interactive) and the Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University. Lee was appointed by Governor Quinn to the Illinois Economic Recovery Commission in 2009. He is also an officer and director of the Gastro-Intestinal Research Foundation (GIRF). Lee practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. He holds a JD degree from the University of Chicago Law School.

back to top

Lisa Suennen

Managing Partner at Venture Valkyrie Consulting, LLC

Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, LLC, a consulting firm providing advisory services to companies, organizations and private equity firms in the healthcare field.

Additionally, Lisa is a Senior Advisor to Psilos Group, a healthcare-focused venture capital and growth equity firm that focuses on the healthcare information technology, healthcare services and medical device sectors. Lisa was a co-founder of Psilos Group and a Partner at the firm from 1998-2014.

Prior to Psilos, Lisa was at Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and product management in companies in the high technology field.

Lisa is currently a a Board Member of the Dignity Health Foundation, and Board Member of health IT company Beyond Lucid Technologies, a Board Member of medical device company AngioScore, a member of the Qualcomm Life Advisory Board, and an Advisor to the California Health Care Foundation Innovation Fund. Lisa also serves as an Advisor to innovation consulting firm Accelevate, Inc. She previously served as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program.

Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley, where she is now Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University. Lisa is also a visiting lecturer at the U.C. Berkeley Haas School of Business where she teaches the annual course on healthcare venture capital.

Lisa also writes a widely read blog on healthcare and healthcare investing at She has recently published her first book, entitled: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology, coauthored with Dr. David Shaywitz.

back to top

Eric Topol, MD

Director, Scripps Translational Science Institute

Eric Topol, MD, is an innovator and pioneer in the fields of wireless medicine and genomics. In addition to serving as co-founder and vice chairman of the West Health Institute, he is the director of the Scripps Translational Science Institute, a National Institute of Health-funded program of the Clinical and Translational Science Award Consortium. He is also professor of genomics at The Scripps Research Institute; chief academic officer and holder of the Gary and Mary West Chair of Innovative Medicine at Scripps Health; and a senior consultant cardiologist practitioner at Scripps Clinic. Dr. Topol formerly served on the faculty of Case Western Reserve University as a professor in genetics, chaired the Department of Cardiovascular Medicine at Cleveland Clinic for 15 years and founded the Cleveland Clinic Lerner College of Medicine. His work in the genomics of heart attack led to the discovery of key genes, which were recognized among the American Heart Association’s Top 10 research advances in 2002 and 2004. Dr. Topol has been elected to the Institute of Medicine of the National Academy of Sciences, named as one of the 12 “Rock Stars of Science” in GQ and one of the Top 100 Most Influential People in Health Care in 2011, and is recognized by the Thomson-Reuters Institute of Scientific Information as one of the Top 10-cited biomedical researchers in medicine in the past decade.

back to top

Dr. Chris Wasden

Executive Director, Sorenson Center for Discovery and Innovation, University of Utah

Dr. Chris Wasden is the Executive Director of the Sorenson Center for Discovery and Innovation at the University of Utah. Previously he was a Managing Director at PwC and the Global Healthcare Innovation Leader. As a global thought leader on Digital Health and the role that Social, Mobile, Analytic and Cloud technologies are transforming healthcare he has written and published over 40 articles and reports on the topic, and he speaks at over 30 events each year on how Digital Health is transforming the practice of medicine, the delivery of care, and the creation of an entirely new wellness paradigm based upon objective measures that lead to greater engagement and changes in human behavior. He advises leading companies on how mobile sensors and Digital Health innovations can create new markets and opportunities (AT&T, Telefonica, Vodafone, Swisscom, Sharp, HCSC, Nokia, RIM, Roche Diagnostics, Eisai Pharmaceuticals, Genentech, Partners Healthcare, just to name a few). He is a named inventor on 11 issued patents and has been a leader in 10 different startups where he developed many of his ideas around the innovation cycle and lifecycle and how fast, frequent, frugal, and failure accelerates innovation. Dr. Wasden has a doctorate in human and organizational learning from George Washington University in Washington, DC, an MBA from the UCLA Anderson School, and bachelor degrees in accounting (BS) and Asian studies (BA) from Brigham Young University in Provo, Utah.

back to top

Dr. Andrew Watson

Medical Director, UPMC Telemedicine

Dr. Andrew Rose Watson is the Medical Director and the initial employee of the Center for Connected Medicine, a thought leadership center showcasing the transformation of health care and the creation of a connected medicine strategy. This is the largest collaborative executive briefing center in the United States located in UPMC’s executive headquarters in Pittsburgh. The Center is a joint venture between founding partners UPMC, IBM, GE, ALU and Verizon, and nine strategic partners. Dr. Watson has hosted over 600 tours for over 8,000 visitors from around the world.

back to top

back to top